We are delighted to welcome Dr John Connell to MAC who will lead our pharmacodynamic offering. Dr Connell completed his PhD at the University of Manchester in 1996 and has over 25 years experience in Clinical Research. The majority of his research has been focused on the application of specialist scientific techniques, including healthy volunteer pharmacodynamic models, in early clinical development.
Dr Connell previously worked as Global Vice President of Pharmacodynamics with ICON Development Solutions for 18 years and contributed to over 200 studies at ICON’s UK and US clinics, covering a wide range of therapeutic indications. Dr Connell joins MAC as Chief Research and Development Officer and will work closely with the Translational Research Department, leading their pharmacodynamic work in both healthy volunteers and patient populations.
